THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW

Detalhes bibliográficos
Autor(a) principal: Barbosa, João Lucas Gaspar
Data de Publicação: 2020
Outros Autores: Gomes, Ludmila Aparecida Pereira, Silva, Jórdan Barros da
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista JRG de Estudos Acadêmicos
Texto Completo: http://revistajrg.com/index.php/jrg/article/view/61
Resumo: A new type of coronavirus appeared in the city of Wuhan in China in 2019. SARS-COV-2 is a single-stranded positive sense RNA virus, surrounded by four proteins, called Spike (S), Envelope (E), Membrane (M) and Nucleocapsid (N). The new coronavirus has been a challenge for healthcare professionals due to the lack of effective treatment against the disease. The aim of the present study was to seek information about the main therapeutic options currently employed in Covid-19 treatment. Thus, it was possible to identify that several of these drugs for the treatment of SARS-CoV-2 show promising results, but they still lack more information and studies, therefore, there is no safe and effective treatment. 
id JRG_167f61cf067b3aa1d394bfa78c2821e5
oai_identifier_str oai:ojs2.revistajrg.com:article/61
network_acronym_str JRG
network_name_str Revista JRG de Estudos Acadêmicos
repository_id_str
spelling THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEWOPÇÕES TERAPÊUTICAS EMPREGADAS NO TRATAMENTO DA COVID – 19: UMA REVISÃO LITERÁRIACovid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.A new type of coronavirus appeared in the city of Wuhan in China in 2019. SARS-COV-2 is a single-stranded positive sense RNA virus, surrounded by four proteins, called Spike (S), Envelope (E), Membrane (M) and Nucleocapsid (N). The new coronavirus has been a challenge for healthcare professionals due to the lack of effective treatment against the disease. The aim of the present study was to seek information about the main therapeutic options currently employed in Covid-19 treatment. Thus, it was possible to identify that several of these drugs for the treatment of SARS-CoV-2 show promising results, but they still lack more information and studies, therefore, there is no safe and effective treatment. Um novo tipo de coronavírus surgiu na cidade de Wuhan na China em 2019. SARS-COV-2 é um vírus de RNA de fita simples senso positivo, envolto por quatro proteínas, denominadas Spike (S), Envelope (E), Membrana (M) e Nucleocapsídeo (N). O novo coronavírus vem sendo um desafio para os profissionais da saúde devido à falta de tratamento eficaz contra a doença. O objetivo do presente estudo foi buscar informações a respeito das principais opções terapêuticas atualmente empregadas no tratamento Covid-19. Assim, foi possível identificar que vários destes medicamentos para o tratamento da SARS-CoV-2 apresentam resultados promissores, porém ainda carecem de mais informações e estudos, não havendo, portanto, um tratamento seguro e eficaz. Editora JRG2020-11-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigo avaliado pelos Paresapplication/pdfhttp://revistajrg.com/index.php/jrg/article/view/6110.5281/zenodo.4245243JRG Journal of Academic Studies; Vol. 3 No. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-293JRG Journal of Academic Studies ; Vol. 3 Núm. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-293JRG Journal of Academic Studies; V. 3 N. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-293Revista JRG de Estudos Acadêmicos ; v. 3 n. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-2932595-1661reponame:Revista JRG de Estudos Acadêmicosinstname:Editora JRGinstacron:JRGporenghttp://revistajrg.com/index.php/jrg/article/view/61/85http://revistajrg.com/index.php/jrg/article/view/61/86https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBarbosa, João Lucas Gaspar Gomes, Ludmila Aparecida Pereira Silva, Jórdan Barros da 2020-12-16T02:11:14Zoai:ojs2.revistajrg.com:article/61Revistahttp://revistajrg.com/index.php/jrgPRIhttp://revistajrg.com/index.php/jrg/oaiprofessorjonas@gmail.com||2595-16612595-1661opendoar:2020-12-16T02:11:14Revista JRG de Estudos Acadêmicos - Editora JRGfalse
dc.title.none.fl_str_mv THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
OPÇÕES TERAPÊUTICAS EMPREGADAS NO TRATAMENTO DA COVID – 19: UMA REVISÃO LITERÁRIA
title THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
spellingShingle THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
Barbosa, João Lucas Gaspar
Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.
Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.
title_short THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
title_full THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
title_fullStr THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
title_full_unstemmed THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
title_sort THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
author Barbosa, João Lucas Gaspar
author_facet Barbosa, João Lucas Gaspar
Gomes, Ludmila Aparecida Pereira
Silva, Jórdan Barros da
author_role author
author2 Gomes, Ludmila Aparecida Pereira
Silva, Jórdan Barros da
author2_role author
author
dc.contributor.author.fl_str_mv Barbosa, João Lucas Gaspar
Gomes, Ludmila Aparecida Pereira
Silva, Jórdan Barros da
dc.subject.por.fl_str_mv Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.
Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.
topic Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.
Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.
description A new type of coronavirus appeared in the city of Wuhan in China in 2019. SARS-COV-2 is a single-stranded positive sense RNA virus, surrounded by four proteins, called Spike (S), Envelope (E), Membrane (M) and Nucleocapsid (N). The new coronavirus has been a challenge for healthcare professionals due to the lack of effective treatment against the disease. The aim of the present study was to seek information about the main therapeutic options currently employed in Covid-19 treatment. Thus, it was possible to identify that several of these drugs for the treatment of SARS-CoV-2 show promising results, but they still lack more information and studies, therefore, there is no safe and effective treatment. 
publishDate 2020
dc.date.none.fl_str_mv 2020-11-04
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigo avaliado pelos Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://revistajrg.com/index.php/jrg/article/view/61
10.5281/zenodo.4245243
url http://revistajrg.com/index.php/jrg/article/view/61
identifier_str_mv 10.5281/zenodo.4245243
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv http://revistajrg.com/index.php/jrg/article/view/61/85
http://revistajrg.com/index.php/jrg/article/view/61/86
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Editora JRG
publisher.none.fl_str_mv Editora JRG
dc.source.none.fl_str_mv JRG Journal of Academic Studies; Vol. 3 No. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-293
JRG Journal of Academic Studies ; Vol. 3 Núm. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-293
JRG Journal of Academic Studies; V. 3 N. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-293
Revista JRG de Estudos Acadêmicos ; v. 3 n. 7 (2020): Revista JRG de Estudos Acadêmicos; 285-293
2595-1661
reponame:Revista JRG de Estudos Acadêmicos
instname:Editora JRG
instacron:JRG
instname_str Editora JRG
instacron_str JRG
institution JRG
reponame_str Revista JRG de Estudos Acadêmicos
collection Revista JRG de Estudos Acadêmicos
repository.name.fl_str_mv Revista JRG de Estudos Acadêmicos - Editora JRG
repository.mail.fl_str_mv professorjonas@gmail.com||
_version_ 1797068983859412992

Registros relacionados